Valuation GC Genome Corporation

Stocks

End-of-day quote Korea S.E. Other stock markets 2026-08-10			5-day change	1st Jan Change
5,470.00 ^KRW	+4.59%		+18.91%	-19.79%

12-09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
25-06-12	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027
Market Cap ¹	161,298	129,370	-
Change	-	-19.79%	-
Enterprise Value (EV) ¹	161.3	69.97	60.57
Change	-	-56.62%	-13.43%
P/E	36.9x	-	-
PBR	-	-	-
PEG	-0x	-	-
Capitalization / Revenue	-	3.32x	2.65x
EV / Revenue	-	1.79x	1.24x
EV / EBITDA	-	-	-
EV / EBIT	-	17.5x	8.65x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	185	-	-
Distribution rate	-	-	-
Net sales ¹	-	39	48.8
EBITDA	-	-	-
EBIT ¹	-	4	7
Net income	4.044	-	-
Net Debt ¹	-	-59.4	-68.8
Reference price ³	6,820.00	5,470.00	5,470.00
Nbr of stocks (in thousands)	23,651	23,651	-
Announcement Date	3/16/26	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GC GENOME CORPORATION	-	1.65x	-	-	87.76M
NATERA, INC.	-223.46x	15.7x	-283.06x	-.--%	46.43B
LABCORP HOLDINGS INC.	23.21x	2.11x	12.07x	0.91%	25.88B
SONIC HEALTHCARE LIMITED	18.14x	1.39x	7.87x	4.83%	7.76B
RADNET, INC.	371.21x	-	-	-	5.69B
DR. LAL PATHLABS LIMITED	51.92x	9.61x	33.11x	0.96%	3.39B
GENEDX HOLDINGS CORP.	-24.09x	-	-	-	2.3B
NEOGENOMICS, INC.	-55.93x	-	-	-.--%	2.13B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	35.33x	1.79x	13.65x	1.45%	1.99B
DIAN DIAGNOSTICS GROUP CO.,LTD.	31.22x	1.21x	9.58x	0.79%	1.84B
Average	25.28x	4.78x	-34.46x	1.28%	9.75B
Weighted average by Cap.	-75.87x	9.53x	-144.47x	0.77%